Miguel Medina
About Miguel Medina
Miguel Medina is a Regional Account Manager at Vizgen, where he specializes in MERFISH technology and the MERSCOPE platform for spatial genomics. He has extensive experience in account management across several biotechnology companies, including STEMCELL Technologies, ACEA Biosciences, and Bio-Techne.
Current Role at Vizgen
Miguel Medina serves as the Regional Account Manager at Vizgen, a position he has held since 2021. In this role, he engages in resolving individual transcripts with nanometer-scale resolution through combinatorial labeling, sequential imaging, and error-robust barcoding. He utilizes the MERSCOPE platform, which is recognized as the first commercially available high-plex single-cell spatial genomics platform, to enhance the company's offerings in spatial genomics.
Previous Experience in Life Sciences
Prior to his current role, Miguel Medina accumulated extensive experience in the life sciences sector. He worked at STEMCELL Technologies as an Account Manager from 2012 to 2015, followed by a position at ACEA Biosciences as Regional Account Manager from 2015 to 2016. He also served as a Genomic Account Manager at HTG Molecular Diagnostics from 2016 to 2018 and as an Account Executive at Bio-Techne from 2018 to 2021. Additionally, he held a role as a Tech Rep at BioHouston from 2012 to 2013.
Educational Background
Miguel Medina has a strong academic background in the life sciences. He earned a Ph.D. in Immunology from Baylor College of Medicine, where he studied from 2001 to 2010. He also holds a Master's Degree in Biotechnology from the University of North Texas Health Science Center, which he completed from 1999 to 2001. His educational foundation has equipped him with the knowledge necessary for his roles in the biotechnology field.
Research and Technical Expertise
In his current position, Miguel Medina works with MERFISH technology, which is designed to provide high detection efficiency for spatially profiling gene expression across whole tissues. His expertise in this area is complemented by his previous experience as a Post-doctoral Fellow at MD Anderson Cancer Center from 2011 to 2012, where he further developed his skills in molecular biology and genomics.